Daniel Pinschewer is founder and Chief Scientific Officer (CSO) of Hookipa and is responsible for enhancing Hookipa’s research capabilities. After graduating from the University of Zurich Medical School in 2000, he became a postdoctoral researcher. He specialised in molecular virology, working alongside Juan Carlos de la Torre (The Scripps Research Institute, USA), and in immunology with Rolf Zinkernagel and Hans Hengartner (University of Zurich, Switzerland). In 2007, he was appointed Associate Professor of Immunology at the University of Geneva Medical School and, in 2013, was recruited to the University of Basel, where he continues to serve as a Professor of Virology. Throughout his career he has been recognised for his contributions to the scientific community, including receiving awards from the European Research Council (ERC starting grant) and from the Swiss National Science Foundation (stipendiary professorship). National and international honors include; the Georges-Köhler-Prize of the German Society for Immunology, the Loeffler-Frosch-Prize of the Society for Virology, the Debiopharm Group Life Sciences Award, the Pfizer Research Prize, and the Prix Leenaards. Daniel’s research discoveries have formed the technological foundation on which Hookipa is founded.